A recent patient-led case series highlights the potential benefits of extended courses of Pfizer Inc's (NYSE:PFE) Paxlovid ...

The findings of a study, headed by the University’s Dr Merchant, is one of the first meta-analyses carried out on multiple independent lactoferrin clinical trials. The study has made evident that the ...

Merck & Co – known as MSD outside of the US and Canada – and Ridgeback Biotherapeutics have initiated a late-stage study to evaluate an investigational oral antiviral COVID-19 drug in adults who are ...

Covid-19 antiviral drugs for humans are getting a new lease on life in post-pandemic China, as cat owners seize on them as ...

Japan approves SIGA's TEPOXX, the first antiviral for orthopoxviruses, for smallpox, mpox, cowpox, and vaccine-related complications. Approval is based on 15 clinical trials and pivotal animal ...

skku.edu Objective The cost-effectiveness of antiviral treatment in adult immune-tolerant (IT) phase chronic hepatitis B (CHB) patients is uncertain. Design We designed a Markov model to compare ...

Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment. Despite national ...

Participants took Paxlovid courses ranging from 7.5 to 30 days, often in combination with other medications or supplements ... Extended antiviral courses have precedent in other conditions ...